NCT00617890 2018-08-23A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)Merck Sharp & Dohme LLCPhase 2 Terminated219 enrolled 13 charts